JPWO2023085392A1 - - Google Patents
Info
- Publication number
- JPWO2023085392A1 JPWO2023085392A1 JP2023559919A JP2023559919A JPWO2023085392A1 JP WO2023085392 A1 JPWO2023085392 A1 JP WO2023085392A1 JP 2023559919 A JP2023559919 A JP 2023559919A JP 2023559919 A JP2023559919 A JP 2023559919A JP WO2023085392 A1 JPWO2023085392 A1 JP WO2023085392A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021184512 | 2021-11-12 | ||
| PCT/JP2022/042029 WO2023085392A1 (ja) | 2021-11-12 | 2022-11-11 | 抗SARS-CoV-2薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023085392A1 true JPWO2023085392A1 (https=) | 2023-05-19 |
| JPWO2023085392A5 JPWO2023085392A5 (https=) | 2025-11-17 |
Family
ID=86335828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559919A Pending JPWO2023085392A1 (https=) | 2021-11-12 | 2022-11-11 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250325547A1 (https=) |
| EP (1) | EP4431151A4 (https=) |
| JP (1) | JPWO2023085392A1 (https=) |
| CN (1) | CN118302413A (https=) |
| WO (1) | WO2023085392A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117362234A (zh) * | 2023-09-25 | 2024-01-09 | 苏州凯瑞医药科技有限公司 | 一种5-溴-7氯-1h吲唑的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007098047A2 (en) | 2006-02-16 | 2007-08-30 | The Mclean Hospital Corporation | Methods and compositions for the treatment of parkinson's disease |
| CN110214011A (zh) | 2017-01-19 | 2019-09-06 | 国立大学法人鹿儿岛大学 | 抗严重发热伴血小板减少综合征病毒的药物 |
| JP7176767B2 (ja) | 2017-04-13 | 2022-11-22 | 国立大学法人 鹿児島大学 | 新規なアモジアキン類似体およびその使用方法 |
| CN111303055B (zh) * | 2020-03-05 | 2021-12-24 | 中国农业科学院兰州畜牧与兽药研究所 | 喹唑啉衍生物及其制备方法和用途 |
| WO2021183463A1 (en) * | 2020-03-09 | 2021-09-16 | President And Fellows Of Harvard College | Compositions and methods for treating coronavirus |
| US20230346820A1 (en) * | 2020-05-05 | 2023-11-02 | The Scripps Research Institute | Methods and compositions for the treatment of sars-cov-2 |
| WO2021235390A1 (ja) * | 2020-05-18 | 2021-11-25 | 国立大学法人鹿児島大学 | 抗SARS-CoV-2薬 |
| JP2021184512A (ja) | 2020-05-21 | 2021-12-02 | 株式会社リコー | 画像形成装置 |
-
2022
- 2022-11-11 JP JP2023559919A patent/JPWO2023085392A1/ja active Pending
- 2022-11-11 CN CN202280074839.2A patent/CN118302413A/zh active Pending
- 2022-11-11 US US18/708,827 patent/US20250325547A1/en active Pending
- 2022-11-11 EP EP22892890.9A patent/EP4431151A4/en active Pending
- 2022-11-11 WO PCT/JP2022/042029 patent/WO2023085392A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4431151A4 (en) | 2025-02-26 |
| WO2023085392A1 (ja) | 2023-05-19 |
| CN118302413A (zh) | 2024-07-05 |
| EP4431151A1 (en) | 2024-09-18 |
| US20250325547A1 (en) | 2025-10-23 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A529 | Written submission of copy of amendment under article 34 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A5211 Effective date: 20240419 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251107 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251107 |